Utilization and Costs for Compliant Patients Initiating Therapy With Pioglitazone or Rosiglitazone Versus Insulin in a Medicaid Fee-for-Service Population

OBJECTIVES: To compare health care utilization and costs for type 2 diabetes patients initiating therapy with one of two thiazolidinediones (TZDs, pioglitazone or rosiglitazone) or insulin in a Medicaid population. METHODS: The study used a retrospective cohort design and included type 2 diabetes pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalsekar, Iftekhar, Iyer, Shrividya, Mody, Reema, Rajagopalan, Rukmini, Kavookjian, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437362/
https://www.ncbi.nlm.nih.gov/pubmed/16515370
http://dx.doi.org/10.18553/jmcp.2006.12.2.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437362/
https://www.ncbi.nlm.nih.gov/pubmed/16515370
http://dx.doi.org/10.18553/jmcp.2006.12.2.121

Ejemplares similares